About
At GenEdit, we aim to overcome the existing limitations in genetic medicine so we can positively impact the lives of as many people as possible.
Our co-founders Kunwoo Lee, Ph.D., Hyo Min Park, Ph.D., and Niren Murthy, Ph.D., worked closely with Nobel Laureate Jennifer Doudna, Ph.D., (Chemistry, 2020) at UC Berkeley and recognized that identifying the right delivery strategy was the critical step in realizing the potential of CRISPR/Cas9 and other genetic medicines.
GenEdit’s mission is to develop innovative therapies through targeted delivery of genetic medicines. With our team’s collective expertise, we are currently advancing novel therapies and realizing our vision to revolutionize genetic medicine through therapies that rewrite patient health.